On demand content from the fifth triMS.online conference
Saúl Reyes Niño, Colombia (Chair)
Early signs of cognitive problems in MS: how to identify them
Roberta Lanzillo, Italy
Coping with cognitive symptoms
Lauren Krupp, USA
Q&A
Live debate
Neuropsychological assessments for MS must offer greater precision than the SDMT and BICAMS to be clinically useful
Saúl Reyes Niño, Colombia (Chair)
Fernando Cáceres, Argentina
Dawn Langdon, UK
BMS sponsored satellite symposium
The emerging use of novel biomarkers in MS
Gavin Giovannoni, UK
Fatigue in MS: impact, challenges and potential solutions
Tiffany Braley, USA
Visualizing hidden progression-related inflammation in the MS brain in vivo
Laura Airas, Finland
Q&A
Invisible symptoms and quality of life
Ruth Stross, UK
Live debate
'Invisible' symptoms of MS should influence DMT choice
Saúl Reyes Niño, Colombia (Chair)
Sarah Morrow, Canada
Juzar Hooker, Kenya
Merck sponsored satellite symposium
Invisible challenges of MS: lessons from cladribine tablets
Sharmilee Gnanapavan, UK
Dimitrios Karussis, Israel
Teaching session
COVID-19 and vaccination in MS
Gavin Giovannoni, UK
Q&A
Meeting close
Chair’s closing remarks
Saúl Reyes Niño, Colombia
MS Brain Health: Meet the Expert session
Jeremy Hobart, UK
Merck: Meet the Expert session
To vaccinate or not to vaccinate? Lessons from Israel
Dimitrios Karussis, Israel
